DeepMed Research

National Institute of Mental Health, Dhaka

🇧🇩Bangladesh

Country: 🇧🇩Bangladesh

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2

Phase 1

Completed

Conditions: CB1
PET
Cannabinoid
Brain Imaging

First Posted Date: 2008-01-21

Last Posted Date: 2017-10-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 18

Registration Number: NCT00598286

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Combining Medications to Enhance Depression Outcomes

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: SSRI + placebo
Drug: Escitalopram + Bupropion SR
Drug: Venlafaxine XR + Mirtazapine

First Posted Date: 2008-01-11

Last Posted Date: 2014-04-23

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 665

Registration Number: NCT00590863

Locations: 🇺🇸
Northwestern Psychiatric Outpatient Treatment Care Center, Chicago, Illinois, United States
🇺🇸
Tuscalossa VA Mental Health Clinic, Tuscaloosa, Alabama, United States
🇺🇸
UCLA Internal Medicine Clinic, Los Angeles, California, United States

and more 12 locations

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Phase 2

Terminated

Conditions: Schizophrenia
Memory Disorders
Cognition Disorders

Interventions: Drug: Atomoxetine
Procedure: Functional magnetic resonance imaging
Procedure: Neuropsychological Testing
Drug: Placebo

First Posted Date: 2007-10-23

Last Posted Date: 2013-06-14

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 11

Registration Number: NCT00548327

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis

Phase 1

Completed

Conditions: Atherosclerosis
Healthy

First Posted Date: 2007-10-23

Last Posted Date: 2012-04-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 5

Registration Number: NCT00547976

Locations: 🇺🇸
Suburban Hospital, Bethesda, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Phase 1

Completed

Conditions: Excitatory Amino Acid Receptors
mGlur5 Protein
Drug Kinetics
Glutamate Receptor
PET Scan
Healthy

First Posted Date: 2007-10-03

Last Posted Date: 2018-07-05

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 50

Registration Number: NCT00538798

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

Completed

Conditions: Depression

First Posted Date: 2007-09-19

Last Posted Date: 2008-09-22

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 300

Registration Number: NCT00532103

Locations: 🇺🇸
Clinical Research Institute, Wichita, Kansas, United States
🇺🇸
Vine Hill Community Clinic, Nashville, Tennessee, United States
🇺🇸
MGH/Northshore Medical Center (Salem Psychiatric Facility), Salem, Massachusetts, United States

and more 12 locations

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB

Phase 1

Completed

Conditions: Healthy
Neurocysticercosis

First Posted Date: 2007-09-11

Last Posted Date: 2018-07-05

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 24

Registration Number: NCT00527579

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28

Phase 1

Completed

Conditions: Neurocysticercosis
Healthy

First Posted Date: 2007-09-10

Last Posted Date: 2019-12-12

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 18

Registration Number: NCT00526916

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder

Phase 2

Withdrawn

Conditions: Bipolar Disorder

First Posted Date: 2007-08-07

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Mental Health (NIMH)

Registration Number: NCT00512616

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Antidepressant Effects of NR2B in Major Depression

Phase 1

Completed

Conditions: Major Depression

Interventions: Drug: MK-0657
Drug: Placebo

First Posted Date: 2007-05-11

Last Posted Date: 2012-08-03

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 5

Registration Number: NCT00472576

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy